UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Lazard
LAZ
$4.31B
| $1.49M | ﹤0.01% |
40,277
-24,544
| -38% | -$979K |
|
1527
Pegasystems
PEGA
$5.38B
| $1.49M | ﹤0.01% |
62,118
+13,362
| +27% | +$350K |
|
1528
Pacira BioSciences
PCRX
$997M
| $1.48M | ﹤0.01% |
34,340
+4,983
| +17% | +$233K |
|
1529
Ormat Technologies
ORA
$6.65B
| $1.48M | ﹤0.01% |
28,222
+2,059
| +8% | +$108K |
|
1530
Simmons First National
SFNC
$3.39B
| $1.47M | ﹤0.01% |
60,971
+7,171
| +13% | +$193K |
|
1531
Boston Beer
SAM
$1.92B
| $1.47M | ﹤0.01% |
6,092
| – | – |
|
|
P
1532
DELISTED
Pandora Media Inc
P
| $1.47M | ﹤0.01% |
181,244
-6,718
| -4% | -$58K |
|
|
LGF.B
1533
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.47M | ﹤0.01% |
98,470
+19,318
| +24% | +$349K |
|
1534
Coherent
COHR
$74.2B
| $1.46M | ﹤0.01% |
45,027
+6,751
| +18% | +$252K |
|
|
DNR
1535
DELISTED
Denbury Resources, Inc.
DNR
| $1.46M | ﹤0.01% |
854,232
+82,124
| +11% | +$283K |
|
1536
Minerals Technologies
MTX
$2.34B
| $1.46M | ﹤0.01% |
28,426
+3,265
| +13% | +$182K |
|
1537
Brady Corp
BRC
$4.57B
| $1.46M | ﹤0.01% |
33,546
+1,624
| +5% | +$67.7K |
|
|
TPH
1538
DELISTED
Tri Pointe Homes
TPH
| $1.45M | ﹤0.01% |
132,586
+18,299
| +16% | +$216K |
|
1539
Evertec
EVTC
$1.78B
| $1.45M | ﹤0.01% |
50,421
+17,976
| +55% | +$471K |
|
1540
Tandem Diabetes Care
TNDM
$1.56B
| $1.44M | ﹤0.01% |
+38,023
| New | +$1.34M |
|
1541
Moelis & Co
MC
$4.94B
| $1.44M | ﹤0.01% |
41,988
+301
| +0.7% | +$12.8K |
|
1542
Bloomin' Brands
BLMN
$938M
| $1.44M | ﹤0.01% |
80,262
-230
| -0.3% | -$4.53K |
|
1543
WD-40
WDFC
$3.15B
| $1.43M | ﹤0.01% |
7,816
+1,222
| +19% | +$207K |
|
1544
Arcosa
ACA
$7.11B
| $1.43M | ﹤0.01% |
+51,723
| New | +$1.42M |
|
1545
Caesars Entertainment
CZR
$6.14B
| $1.43M | ﹤0.01% |
39,493
+5,509
| +16% | +$219K |
|
1546
Cogent Communications
CCOI
$508M
| $1.43M | ﹤0.01% |
31,560
+1,136
| +4% | +$56.2K |
|
|
AXE
1547
DELISTED
Anixter International Inc
AXE
| $1.42M | ﹤0.01% |
26,191
+648
| +3% | +$40.8K |
|
|
GES
1548
DELISTED
Guess Inc
GES
| $1.42M | ﹤0.01% |
68,443
-15,598
| -19% | -$330K |
|
1549
Moog Inc Class A
MOG.A
$12.8B
| $1.42M | ﹤0.01% |
18,268
-4,703
| -20% | -$372K |
|
|
BEAT
1550
DELISTED
BioTelemetry, Inc.
BEAT
| $1.41M | ﹤0.01% |
23,683
+4,271
| +22% | +$256K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.